机译:基于组织微阵列的PD-L1表达评估和整个部分方法的外部质量评估,患者切除,阶段I-III,非小细胞肺癌:ETOP Lungcape项目
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Pathol Amsterdam Netherlands;
机译:基于组织微阵列的PD-L1表达评估和整个部分方法的外部质量评估,患者切除,阶段I-III,非小细胞肺癌:ETOP Lungcape项目
机译:非小细胞肺癌中手术分子和成对组织微阵列的22C3 PD-L1表达的比较
机译:核糖核苷酸还原酶亚单位-2和胸苷合酶的表达与切除阶段I-III非小细胞肺癌患者的预后差相关
机译:手术切除的Ⅰ期非小细胞肺癌患者FDG摄取是复发的生物学预后因素
机译:PD-L1表达在非小细胞肺癌中的调节及后果
机译:辅助化疗治疗切除的非小细胞肺癌患者黏蛋白表达的预后意义的交叉验证分析:IALTJBR.10和ANITA的结果
机译:组织微阵列分析Runx3和三甲基化组蛋白H3赖氨酸27在手术切除阶段I期非小细胞肺癌患者中的预后价值分析